Finance
Beta
search
Search or ask
settings
Theme
mobile
Device default
✓
dark_mode
Dark theme
light_mode
Light theme
Search labs
feedback
Send feedback
ເຂົ້າສູ່ລະບົບ
Lists
playlist_add
New
BBC
Research
BBC:NYSEARCA
check_indeterminate_small
Virtus Biotech Clinical Trials ETF
US$52,79
arrow_upward
+2,41%
(
+1,24
) 1D
2 ກ.ລ., 20 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-4 · USD
area_chart
Area
stacked_line_chart
Compare
search
close
All symbols
monitoring
Indicators
No data
1D
5D
1M
6M
YTD
1Y
5Y
MAX
Symbol
Price
Change
% Change
Overview
insights_auto
Generating top insights for BBC...
Open
US$52,08
High
US$52,79
Low
US$51,64
Avg. vol.
໒໔,໐໕ ພັນ
Volume
໓,໒໖ ພັນ
52-wk high
US$53,52
52-wk low
US$19,87
Open
US$52,08
High
US$52,79
Low
US$51,64
Avg. vol.
໒໔,໐໕ ພັນ
Volume
໓,໒໖ ພັນ
52-wk high
US$53,52
52-wk low
US$19,87
Related assets
SBIO
ALPS Medical Breakthroughs ETF
US$64,90
+2,45%
arrow_upward
BBP
Virtus Biotech ETF
US$99,08
+3,18%
arrow_upward
XBI
State Street SPDR S&P Biotech ETF
US$160,46
+2,50%
arrow_upward
IBB
iShares Biotechnology ETF
US$195,70
+2,93%
arrow_upward
News stories
From sources across the web
Yahoo Finance
·
30 ນາທີກ່ອນ
SPYI vs. JEPI: Which S&P 500 Covered-Call ETF Pays You More Safely?
MSN
·
22 ນາທີກ່ອນ
Wall Street is buzzing about Alphabet joining the Dow. Income investors should be looking at this stock instead.
MarketBeat
·
35 ນາທີກ່ອນ
Royalty Pharma PLC (NASDAQ:RPRX) Receives Average Recommendation of "Buy" from Analysts
MarketWatch
·
2 ຊົ່ວໂມງກ່ອນ
Why the stock market’s red-hot momentum trade might be headed for a violent unwind this month
Show more
AI content may include mistakes.
Learn more
Help
Send feedback
Privacy
Terms
Disclaimer
Research
edit_square
New thread
notes_spark
Thread history
close
Collapse
expand_content
Expand
What's on your mind?
What's going on with the markets today?
search_spark
Explore what’s possible
travel_explore
Deep Search
add
Add Tool
upload_file
Upload File
travel_explore
Deep Search
arrow_upward
Ask AI
search_spark
AI content may include mistakes.
Learn more
Help
Send feedback
Privacy
Terms
Disclaimer